Gene Therapy of Thromboangiitis Obliterans with Growth Factor Plasmid (VEGF165) and Autologous Bone Marrow Cells.

Barć P, Lubieniecki P, Antkiewicz M, Kupczyńska D, Barć J, Frączkowska-Sioma K, Dawiskiba T, Dorobisz T, Sekula W, Czuwara B, Małodobra-Mazur M, Baczyńska D, Witkiewicz W, Skóra JP, Janczak D

Open source

DOI
10.3390/biomedicines12071506
Published
2024 Jul 6
Container
Biomedicines
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines12071506,
  title = {Gene Therapy of Thromboangiitis Obliterans with Growth Factor Plasmid (VEGF165) and Autologous Bone Marrow Cells.},
  author = {Barć P and Lubieniecki P and Antkiewicz M and Kupczyńska D and Barć J and Frączkowska-Sioma K and Dawiskiba T and Dorobisz T and Sekula W and Czuwara B and Małodobra-Mazur M and Baczyńska D and Witkiewicz W and Skóra JP and Janczak D},
  year = {2024},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines12071506},
  url = {https://doi.org/10.3390/biomedicines12071506}
}

RIS

TY  - JOUR
TI  - Gene Therapy of Thromboangiitis Obliterans with Growth Factor Plasmid (VEGF165) and Autologous Bone Marrow Cells.
AU  - Barć P
AU  - Lubieniecki P
AU  - Antkiewicz M
AU  - Kupczyńska D
AU  - Barć J
AU  - Frączkowska-Sioma K
AU  - Dawiskiba T
AU  - Dorobisz T
AU  - Sekula W
AU  - Czuwara B
AU  - Małodobra-Mazur M
AU  - Baczyńska D
AU  - Witkiewicz W
AU  - Skóra JP
AU  - Janczak D
PY  - 2024
JO  - Biomedicines
DO  - 10.3390/biomedicines12071506
UR  - https://doi.org/10.3390/biomedicines12071506
ER  - 

APA

P, B., P, L., M, A., D, K., J, B., K, F., T, D., T, D., W, S., B, C., M, M., D, B., W, W., JP, S., & D, J. (2024). Gene Therapy of Thromboangiitis Obliterans with Growth Factor Plasmid (VEGF165) and Autologous Bone Marrow Cells.. Biomedicines. https://doi.org/10.3390/biomedicines12071506

Source records